NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations
- PMID: 39331572
- PMCID: PMC11471261
- DOI: 10.1093/bioinformatics/btae585
NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations
Abstract
Motivation: Tumor polyvalent neoantigen mRNA vaccines are gaining prominence in immunotherapy. The design of sequences in vaccine development is crucial for enhancing both the immunogenicity and safety of vaccines. However, a major challenge lies in selecting the optimal sequences from the large pools generated by multiple peptide combinations and synonymous codons.
Results: We introduce NeoDesign, a computational tool designed to tackle the challenge of sequence design. NeoDesign comprises four modules: Library Construction, Optimal Path Filtering, Linker Addition, and λ-Evaluation. It aims to identify the optimal protein sequence for tumor polyvalent neoantigen vaccines by minimizing linker usage, avoiding unexpected neoantigens and functional domains, and simplifying the structure. It also provides a preference scheme to balance mRNA stability and protein expression when designing mRNA sequences for the optimal protein sequence. This tool can potentially improve the sequence design of tumor polyvalent neoantigen mRNA vaccines, thereby significantly advancing immunotherapy strategies.
Availability and implementation: NeoDesign is freely available on https://github.com/HuangLab-Fudan/neoDesign and https://figshare.com/projects/NeoDesign/221704.
© The Author(s) 2024. Published by Oxford University Press.
Conflict of interest statement
None declared.
Figures

References
-
- Asher G, Shaul Y.. p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 2005;4:1015–8. - PubMed
-
- Awad MM, Govindan R, Balogh KN. et al. Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer. Cancer Cell 2022;40:1010–26.e11. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources